JP2024538502A5 - - Google Patents
Info
- Publication number
- JP2024538502A5 JP2024538502A5 JP2024515583A JP2024515583A JP2024538502A5 JP 2024538502 A5 JP2024538502 A5 JP 2024538502A5 JP 2024515583 A JP2024515583 A JP 2024515583A JP 2024515583 A JP2024515583 A JP 2024515583A JP 2024538502 A5 JP2024538502 A5 JP 2024538502A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- compound
- formula
- use according
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL2029166 | 2021-09-10 | ||
| NL2029166 | 2021-09-10 | ||
| PCT/NL2022/050507 WO2023038522A1 (en) | 2021-09-10 | 2022-09-08 | Compositions and methods for treating biofilm disorders and infection |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538502A JP2024538502A (ja) | 2024-10-23 |
| JP2024538502A5 true JP2024538502A5 (https=) | 2025-08-27 |
Family
ID=91357207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024515583A Pending JP2024538502A (ja) | 2021-09-10 | 2022-09-08 | バイオフィルム障害及び感染症を治療するための組成物及び方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240374535A1 (https=) |
| EP (1) | EP4398891A1 (https=) |
| JP (1) | JP2024538502A (https=) |
| CN (1) | CN118175994A (https=) |
| MX (1) | MX2024002878A (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2002048100A2 (de) * | 2000-12-15 | 2002-06-20 | Bayer Aktiengesellschaft | Thiosulfonsäure-s-ester als materialschutzmittel |
| ES2311373B1 (es) * | 2006-09-27 | 2009-12-21 | Dmc Research Center, S.L. | "utilizacion de un compuesto antibacteriano derivado de alliaceas, como aditivos en alimentacion animal". |
-
2022
- 2022-09-08 US US18/690,582 patent/US20240374535A1/en active Pending
- 2022-09-08 EP EP22769406.4A patent/EP4398891A1/en active Pending
- 2022-09-08 MX MX2024002878A patent/MX2024002878A/es unknown
- 2022-09-08 CN CN202280073161.6A patent/CN118175994A/zh active Pending
- 2022-09-08 JP JP2024515583A patent/JP2024538502A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5753699A (en) | Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent | |
| CN101573031B (zh) | 抗微生物组合物 | |
| US8808732B2 (en) | Film forming personal care compositions and methods | |
| EP0856318B1 (en) | Cyanoacrylate compositions comprising an antimicrobial agent | |
| JP2007500697A5 (https=) | ||
| HUE027207T2 (en) | A composition comprising an antibiotic and a dispersant | |
| KR970014765A (ko) | 신경보호제를 이용한 이명의 치료 | |
| JP6265395B2 (ja) | ピロロキノリン化合物と、β−ラクタム系抗微生物剤、ムピロシンまたはクロルヘキシジンとを組み合わせてなる、細菌感染の予防および/または治療薬 | |
| KR20100017153A (ko) | 균막 형성을 처리하기 위한 트리아졸 화합물 | |
| JP2024538502A5 (https=) | ||
| JP2013523707A (ja) | 新規な組み合わせおよび使用 | |
| JP2023518928A5 (https=) | ||
| WO1999023150A1 (en) | Cyanoacrylate polymer compositions comprising an antimicrobial agent | |
| WO2023204274A1 (ja) | 菌叢改善剤 | |
| CN1164271C (zh) | 稳定的丁苄唑啉和氧甲唑啉溶液 | |
| JP5359059B2 (ja) | 外皮用防菌皮膜形成剤 | |
| JP7266597B2 (ja) | 微生物のコロニー形成を抑制するための置換トラン | |
| CN108605976A (zh) | 一种用于抑制和杀灭病菌的抗菌剂 | |
| JPWO2021187592A5 (https=) | ||
| MX2023015404A (es) | Compuestos de azol para el control de plagas de invertebrados. | |
| WO1998030091A1 (en) | Methods for treating non-suturable, superficial wounds by use of cyanoacrylate ester compositions comprising an antimicrobial agent | |
| TW202537520A (zh) | 抗菌組成物及其用途 | |
| Abbas et al. | N-acetylcysteine and ambroxol: Can mucolytics dissolve the resistance of biofilms to antibiotics | |
| WO2022251321A1 (en) | Composition for topical treatment of microbial infections | |
| WO2024141594A1 (en) | Composition comprising more than ten percent by weight of 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one derivatives |